{"id":66627,"date":"2026-04-15T11:29:18","date_gmt":"2026-04-15T05:59:18","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=66627"},"modified":"2026-04-15T11:29:20","modified_gmt":"2026-04-15T05:59:20","slug":"molecular-genetics-of-hypertrophic-cardiomyopathy","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/","title":{"rendered":"Molecular Genetics of Hypertrophic Cardiomyopathy"},"content":{"rendered":"<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/7V5rKjgJQQI?si=FgrK2KAyaW6AXDhd\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n\n<p class=\"wp-block-paragraph\">Hypertrophic Cardiomyopathy (HCM) is primarily recognized as a <strong>disease of the sarcomere<\/strong>\u2014the fundamental contractile unit of the cardiac muscle cell. It is the most common transitionally inherited cardiac disorder, typically following an <strong>autosomal dominant<\/strong> pattern.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Genetic Architecture<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The majority of identifiable mutations in HCM occur in genes encoding proteins of the thick and thin filaments of the sarcomere.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. The &#8220;Big Two&#8221;<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>MYBPC3 (Myosin-binding protein C, cardiac):<\/strong> Mutations often lead to &#8220;haploinsufficiency,&#8221; where the cell doesn&#8217;t produce enough functional protein, leading to gradual structural changes.<\/li>\n\n\n\n<li class=\"\"><strong>MYH7 (\u03b2-myosin heavy chain):<\/strong> These are typically &#8220;missense&#8221; mutations, where the mutant protein interferes with the function of the normal protein. <\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Each of these have been identified in about <a href=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCRESAHA.121.318346\" type=\"link\" id=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCRESAHA.121.318346\">20% each of HCM cases and higher number in larger families<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2. Other Core Sarcomeric Genes<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>TNNT2 (Cardiac troponin T):<\/strong> Notable because mutations here can sometimes cause <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S073510979600530X\" type=\"link\" id=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S073510979600530X\">mild hypertrophy but a high risk of sudden cardiac death (SCD)<\/a>.<\/li>\n\n\n\n<li class=\"\"><strong>TNNI3 (Cardiac troponin I)<\/strong><\/li>\n\n\n\n<li class=\"\"><strong>TPM1 (\u03b1-tropomyosin)<\/strong><\/li>\n\n\n\n<li class=\"\"><strong>MYL2 &amp; MYL3 (Myosin light chains)<\/strong>: These are uncommon causes of HCM, together being responsible for &lt;1% of the HCM cases<\/li>\n\n\n\n<li class=\"\"><strong>ACTC1 (\u03b1-cardiac actin)<\/strong><\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology: The Molecular Mechanism<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The central paradox of HCM at the molecular level is that the mutations often cause <strong>hypercontractility<\/strong> rather than weakness.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>The &#8220;Super-Relaxed&#8221; State (SRX):<\/strong> Recent research highlights that many mutations (especially in <em>MYBPC3<\/em> and <em>MYH7<\/em>) <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10341819\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10341819\/\">disrupt the &#8220;super-relaxed state&#8221; of myosin<\/a>. This unshackles the myosin heads, making them ready to bind to actin more frequently.<\/li>\n\n\n\n<li class=\"\"><strong>Increased ATP Consumption:<\/strong> Because more myosin heads are active, the heart consumes more energy, leading to a cellular energy crisis.<\/li>\n\n\n\n<li class=\"\"><strong>Impaired Relaxation:<\/strong> The excess cross-bridge formation prevents the muscle from relaxing fully, leading to the hallmark diastolic dysfunction seen in HCM.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical Implications of Genetics<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Feature<\/strong><\/td><td><strong>Description<\/strong><\/td><\/tr><\/thead><tbody><tr><td><strong>Genetic Yield<\/strong><\/td><td>Comprehensive testing identifies a causative mutation in roughly <strong>30% to 60%<\/strong> of patients with a clear clinical phenotype.<\/td><\/tr><tr><td><strong>Genotype-Negative HCM<\/strong><\/td><td>Patients who meet clinical criteria but have no identifiable mutation often have a later onset and a lower risk of family transmission.<\/td><\/tr><tr><td><strong>Phenocopies<\/strong><\/td><td>Some genetic disorders &#8220;mimic&#8221; HCM but involve different pathways, such as <strong>Danon disease<\/strong> (LAMP2), <strong>Fabry disease<\/strong> (GLA), or <strong>Friedreich ataxia<\/strong> (FXN).<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Therapeutic Advances<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The molecular understanding of HCM has led to the development of <strong>Cardiac Myosin Inhibitors<\/strong> (e.g., <strong>Mavacamten<\/strong>). These drugs specifically target the molecular defect by <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12494088\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12494088\/\">shifting myosin heads back into the &#8220;super-relaxed&#8221; state<\/a>, reducing the hyper-contractility and relieving the outflow tract obstruction.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Genetic Influence on Arrhythmia Risk<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The relationship between genotype and arrhythmogenesis is one of the most complex areas of HCM management. While hypertrophy itself creates a substrate for re-entry, the molecular defects often precede structural changes, suggesting a &#8220;pro-arrhythmic&#8221; state at the cellular level. The specific gene involved can significantly alter the electrophysiological profile and the risk of Sudden Cardiac Death (SCD):<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. TNNT2 (Troponin T) &#8211; The &#8220;Malignant&#8221; Variant<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Mutations in <em>TNNT2<\/em> are classically associated with a high risk of SCD despite only <strong>mild or even absent hypertrophy<\/strong>. This is a critical clinical &#8220;red flag.&#8221;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Mechanism:<\/strong> These mutations often <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8718794\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8718794\/\">increase calcium sensitivity<\/a>, which shortens the action potential duration and increases susceptibility to ventricular arrhythmias.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">2. MYH7 vs. MYBPC3<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>MYH7:<\/strong> Patients often present earlier in life with more significant hypertrophy and a <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30354366\/\" type=\"link\" id=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30354366\/\">higher incidence of atrial fibrillation<\/a> (AFib) due to progressive left atrial remodeling.<\/li>\n\n\n\n<li class=\"\"><strong>MYBPC3:<\/strong> Often associated with a later onset of symptoms, but once hypertrophy develops, the risk of ventricular tachycardia (VT) remains comparable to other variants.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Redefining ICD Selection<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Current guidelines primarily use clinical markers for ICD placement, but genetics is increasingly being used to &#8220;tip the scale&#8221;:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>The <a href=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/circgenetics.108.836478\" type=\"link\" id=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/circgenetics.108.836478\">&#8220;Multiple Mutation&#8221; Effect<\/a>:<\/strong> Approximately 5% of patients carry more than one mutation (compound or double heterozygous). These patients typically have a much more aggressive course and a higher threshold for early ICD consideration.<\/li>\n\n\n\n<li class=\"\"><strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12278546\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12278546\/\">Sarcomere-Positive vs. Sarcomere-Negative<\/a>:<\/strong> Patients with an identifiable sarcomere mutation generally have a higher risk of SCD compared to those with &#8220;genotype-negative&#8221; HCM, who often have a more benign clinical course.<\/li>\n\n\n\n<li class=\"\"><strong>Non-Sustained Ventricular Tachycardia (NSVT):<\/strong> The frequency and duration of NSVT on Holter monitoring are more concerning in patients with high-risk mutations (like <em>TNNT2<\/em> or <em>ACTC1<\/em>).<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Emerging Electrophysiological Markers<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Research is shifting toward identifying &#8220;pre-phenotypic&#8221; markers in family members who are <strong>G+\/P-<\/strong> (Genotype positive, Phenotype negative):<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>ECG Changes:<\/strong> Deep S-waves in V2\/V3 or <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3603779\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3603779\/\">T-wave inversions can precede wall thickening<\/a>.<\/li>\n\n\n\n<li class=\"\"><strong><a href=\"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/Supplement_1\/jeaf367.295\/8446213\" type=\"link\" id=\"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/Supplement_1\/jeaf367.295\/8446213\">Mechanical Dispersion<\/a>:<\/strong> Using strain imaging to find subtle delays in contraction that correlate with future VT\/VF risk.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Hypertrophic Cardiomyopathy (HCM) is primarily recognized as a disease of the sarcomere\u2014the fundamental contractile unit of the cardiac muscle cell. It is the most common transitionally inherited cardiac disorder, typically following an autosomal dominant pattern. Genetic Architecture The majority of identifiable mutations in HCM occur in genes encoding proteins of the thick and thin filaments [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":66628,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-66627","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Molecular Genetics of Hypertrophic Cardiomyopathy - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molecular Genetics of Hypertrophic Cardiomyopathy - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Hypertrophic Cardiomyopathy (HCM) is primarily recognized as a disease of the sarcomere\u2014the fundamental contractile unit of the cardiac muscle cell. It is the most common transitionally inherited cardiac disorder, typically following an autosomal dominant pattern. Genetic Architecture The majority of identifiable mutations in HCM occur in genes encoding proteins of the thick and thin filaments [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-15T05:59:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-15T05:59:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Molecular-Genetics-of-Hypertrophic-Cardiomyopathy.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1202\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Molecular Genetics of Hypertrophic Cardiomyopathy\",\"datePublished\":\"2026-04-15T05:59:18+00:00\",\"dateModified\":\"2026-04-15T05:59:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/\"},\"wordCount\":728,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Molecular-Genetics-of-Hypertrophic-Cardiomyopathy.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/\",\"name\":\"Molecular Genetics of Hypertrophic Cardiomyopathy - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Molecular-Genetics-of-Hypertrophic-Cardiomyopathy.jpg\",\"datePublished\":\"2026-04-15T05:59:18+00:00\",\"dateModified\":\"2026-04-15T05:59:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Molecular-Genetics-of-Hypertrophic-Cardiomyopathy.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Molecular-Genetics-of-Hypertrophic-Cardiomyopathy.jpg\",\"width\":1202,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/molecular-genetics-of-hypertrophic-cardiomyopathy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molecular Genetics of Hypertrophic Cardiomyopathy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Molecular Genetics of Hypertrophic Cardiomyopathy - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/","og_locale":"en_US","og_type":"article","og_title":"Molecular Genetics of Hypertrophic Cardiomyopathy - All About Cardiovascular System and Disorders","og_description":"Hypertrophic Cardiomyopathy (HCM) is primarily recognized as a disease of the sarcomere\u2014the fundamental contractile unit of the cardiac muscle cell. It is the most common transitionally inherited cardiac disorder, typically following an autosomal dominant pattern. Genetic Architecture The majority of identifiable mutations in HCM occur in genes encoding proteins of the thick and thin filaments [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-04-15T05:59:18+00:00","article_modified_time":"2026-04-15T05:59:20+00:00","og_image":[{"width":1202,"height":675,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Molecular-Genetics-of-Hypertrophic-Cardiomyopathy.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Molecular Genetics of Hypertrophic Cardiomyopathy","datePublished":"2026-04-15T05:59:18+00:00","dateModified":"2026-04-15T05:59:20+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/"},"wordCount":728,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Molecular-Genetics-of-Hypertrophic-Cardiomyopathy.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/","url":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/","name":"Molecular Genetics of Hypertrophic Cardiomyopathy - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Molecular-Genetics-of-Hypertrophic-Cardiomyopathy.jpg","datePublished":"2026-04-15T05:59:18+00:00","dateModified":"2026-04-15T05:59:20+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Molecular-Genetics-of-Hypertrophic-Cardiomyopathy.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Molecular-Genetics-of-Hypertrophic-Cardiomyopathy.jpg","width":1202,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/molecular-genetics-of-hypertrophic-cardiomyopathy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Molecular Genetics of Hypertrophic Cardiomyopathy"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=66627"}],"version-history":[{"count":5,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66627\/revisions"}],"predecessor-version":[{"id":66643,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66627\/revisions\/66643"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/66628"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=66627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=66627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=66627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}